DDX17 overexpression was shown in human HCC, and studies using Ddx17 knockdown human HCC cells and hepatocyte-specific conditional DDX17 knockout mice unraveled an oncogenic role of DDX17 in promoting HCC [123]. Here, DDX17 is linked to hepatocellular carcinoma.